These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
194 related articles for article (PubMed ID: 28740838)
1. A rare case of centronuclear myopathy with Aghbolaghi AG; Lechpammer M Autops Case Rep; 2017; 7(2):43-48. PubMed ID: 28740838 [TBL] [Abstract][Full Text] [Related]
2. DNM2 mutations in Chinese Han patients with centronuclear myopathy. Lin P; Liu X; Zhao D; Dai T; Wu H; Gong Y; Yan C Neurol Sci; 2016 Jun; 37(6):995-8. PubMed ID: 26908122 [TBL] [Abstract][Full Text] [Related]
3. Phenotype variability and histopathological findings in centronuclear myopathy due to DNM2 mutations. Hanisch F; Müller T; Dietz A; Bitoun M; Kress W; Weis J; Stoltenburg G; Zierz S J Neurol; 2011 Jun; 258(6):1085-90. PubMed ID: 21221624 [TBL] [Abstract][Full Text] [Related]
9. Mutational and clinical spectrum of centronuclear myopathy in 9 cases and a literature review of Chinese patients. Wang Q; Yu M; Xie Z; Liu J; Wang Q; Lv H; Zhang W; Yuan Y; Wang Z Neurol Sci; 2022 Apr; 43(4):2803-2811. PubMed ID: 34595679 [TBL] [Abstract][Full Text] [Related]
10. Clinicopathological features of centronuclear myopathy in Japanese populations harboring mutations in dynamin 2. Mori-Yoshimura M; Okuma A; Oya Y; Fujimura-Kiyono C; Nakajima H; Matsuura K; Takemura A; Malicdan MC; Hayashi YK; Nonaka I; Murata M; Nishino I Clin Neurol Neurosurg; 2012 Jul; 114(6):678-83. PubMed ID: 22613877 [TBL] [Abstract][Full Text] [Related]
11. Different in vivo impacts of dynamin 2 mutations implicated in Charcot-Marie-Tooth neuropathy or centronuclear myopathy. Massana Muñoz X; Buono S; Koebel P; Laporte J; Cowling BS Hum Mol Genet; 2019 Dec; 28(24):4067-4077. PubMed ID: 31628461 [TBL] [Abstract][Full Text] [Related]
12. Characterization of the muscle involvement in dynamin 2-related centronuclear myopathy. Fischer D; Herasse M; Bitoun M; Barragán-Campos HM; Chiras J; Laforêt P; Fardeau M; Eymard B; Guicheney P; Romero NB Brain; 2006 Jun; 129(Pt 6):1463-9. PubMed ID: 16585051 [TBL] [Abstract][Full Text] [Related]
13. Clinical and Pathological Features of Korean Patients with DNM2-Related Centronuclear Myopathy. Park YE; Choi YC; Bae JS; Lee CH; Kim HS; Shin JH; Kim DS J Clin Neurol; 2014 Jan; 10(1):24-31. PubMed ID: 24465259 [TBL] [Abstract][Full Text] [Related]
14. Clinical, pathological, and genetic features of dynamin-2-related centronuclear myopathy in China. Chen T; Pu C; Wang Q; Liu J; Mao Y; Shi Q Neurol Sci; 2015 May; 36(5):735-41. PubMed ID: 25501959 [TBL] [Abstract][Full Text] [Related]
15. Reducing dynamin 2 (DNM2) rescues Buono S; Ross JA; Tasfaout H; Levy Y; Kretz C; Tayefeh L; Matson J; Guo S; Kessler P; Monia BP; Bitoun M; Ochala J; Laporte J; Cowling BS Proc Natl Acad Sci U S A; 2018 Oct; 115(43):11066-11071. PubMed ID: 30291191 [TBL] [Abstract][Full Text] [Related]
16. Histopathologic changes in the extraocular muscle in centronuclear myopathy with a Dynamin 2 mutation. Hanna N; Bouhenni R; Gupta B; Abu-Amero KK; Wollmann R; Edward DP Ophthalmic Genet; 2013; 34(1-2):83-6. PubMed ID: 22924779 [TBL] [Abstract][Full Text] [Related]